Diagnostic and Prognostic Value of 18-Fluorodeoxyglucose Positron Emission Tomography in Adrenocortical Carcinoma: A Prospective Comparison with Computed Tomography | Zendy

Sophie Leboulleux | Zendy; Clarisse Dromain | Zendy; G. Bonniaud | Zendy; A. Aupérin | Zendy; Bernard Caillou | Zendy; J. Lumbroso | Zendy; R. Sigal | Zendy; Éric Baudin | Zendy; M. Schlumberger | Zendy

Open Access

Diagnostic and Prognostic Value of 18-Fluorodeoxyglucose Positron Emission Tomography in Adrenocortical Carcinoma: A Prospective Comparison with Computed Tomography

Author(s) -

Sophie Leboulleux,

Clarisse Dromain,

G. Bonniaud,

A. Aupérin,

Bernard Caillou,

J. Lumbroso,

R. Sigal,

Éric Baudin,

M. Schlumberger

Publication year - 2006

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2005-1540

Subject(s) - adrenocortical carcinoma , positron emission tomography , medicine , radiology , tomography , computed tomography , fluorodeoxyglucose , nuclear medicine , positron emission tomography computed tomography , prospective cohort study , positron emission , pathology

Patients with adrenocortical cancer are submitted to multiple imaging procedures for diagnosis of recurrence and staging. The aim of this prospective study was to evaluate the diagnostic and prognostic values of fluorodeoxyglucose (FDG) using a combined positron emission tomography and computed tomography (PET/CT) modality, compared with thoracoabdominopelvic computed tomography (TAP-CT).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research